|
1
|
Comparison of low ionic diluents for use with the Diamed antiglobulin gel test.
|
2002
|
2.50
|
|
2
|
Transfusion-transmitted hepatitis E in a 'nonhyperendemic' country.
|
2006
|
2.43
|
|
3
|
Guidelines on gamma irradiation of blood components for the prevention of transfusion-associated graft-versus-host disease. BCSH Blood Transfusion Task Force.
|
1996
|
2.12
|
|
4
|
Routine antenatal anti-D prophylaxis--is the protection adequate?
|
2011
|
2.12
|
|
5
|
Guidelines for the use of fresh frozen plasma. British Committee for Standards in Haematology, Working Party of the Blood Transfusion Task Force.
|
1992
|
2.07
|
|
6
|
Use of blood products for elective surgery in 43 European hospitals. The Sanguis Study Group.
|
1994
|
2.04
|
|
7
|
Recurrent paroxysmal cold haemoglobinuria in a 3-year-old child: a case report.
|
2003
|
2.01
|
|
8
|
The use of pooled red cells and column techniques for routine red cell antibody detection.
|
1996
|
1.99
|
|
9
|
A survey of the demographics of blood use.
|
2007
|
1.95
|
|
10
|
The annual cost of blood transfusions in the UK.
|
2003
|
1.93
|
|
11
|
How much residual plasma may cause TRALI?
|
2008
|
1.85
|
|
12
|
Autologous transfusion techniques: a systematic review of their efficacy.
|
2004
|
1.84
|
|
13
|
A study of the prevalence of iron deficiency and its related factors in blood donors of Yazd, Iran, 2003.
|
2005
|
1.84
|
|
14
|
Changing indications for red cell transfusion from 2000 to 2004 in the North of England.
|
2006
|
1.82
|
|
15
|
The frequency of anti-C + anti-G in the absence of anti-D in alloimmunized pregnancies.
|
2001
|
1.82
|
|
16
|
Erythrocyte ageing in vivo and in vitro: structural aspects and implications for transfusion.
|
2008
|
1.82
|
|
17
|
Differences in post-operative infection rates between patients receiving autologous and allogeneic blood transfusion: a meta-analysis of published randomized and nonrandomized studies.
|
1996
|
1.82
|
|
18
|
Guidelines for policies on alternatives to allogeneic blood transfusion. 1. Predeposit autologous blood donation and transfusion.
|
2007
|
1.77
|
|
19
|
The clinical significance of blood group antibodies.
|
2002
|
1.76
|
|
20
|
Pathogen inactivation of labile blood products.
|
2001
|
1.75
|
|
21
|
Guidelines for blood grouping and red cell antibody testing during pregnancy. British Committee for Standards in Haematology, Blood Transfusion Task Force.
|
1996
|
1.74
|
|
22
|
Improved strategy for screening prospective blood donors for anaemia.
|
1994
|
1.72
|
|
23
|
Low ionic diluents and the DiaMed antiglobulin gel test.
|
2002
|
1.70
|
|
24
|
The European Blood Directive: a new era of blood regulation has begun.
|
2004
|
1.68
|
|
25
|
Low ferritin levels indicate the need for iron supplementation: strategy to minimize iron-depletion in regular blood donors.
|
2000
|
1.67
|
|
26
|
Guidelines for compatibility procedures in blood transfusion laboratories.
|
2004
|
1.67
|
|
27
|
A comparison of biochemical and functional alterations of rat and human erythrocytes stored in CPDA-1 for 29 days: implications for animal models of transfusion.
|
2000
|
1.66
|
|
28
|
Isolation of human mannan binding lectin, serum amyloid P component and related factors from Cohn fraction III.
|
1997
|
1.63
|
|
29
|
Alloimmunization among patients with transfusion-dependent thalassemia in Taiwan.
|
2006
|
1.60
|
|
30
|
Guidelines for pre-transfusion compatibility procedures in blood transfusion laboratories. British Committee for Standards in Haematology.
|
2012
|
1.60
|
|
31
|
Legislative reforms of the blood transfusion system in Pakistan.
|
2014
|
1.59
|
|
32
|
Prevalence of immediate vasovagal reaction in blood donors visiting two blood banks of Karachi.
|
2009
|
1.58
|
|
33
|
Monoclonal anti-D specificity and Rh D structure: criteria for selection of monoclonal anti-D reagents for routine typing of patients and donors.
|
1995
|
1.58
|
|
34
|
Promoting blood donation: a study of the social profile, attitudes, motivation and experience of donors.
|
1991
|
1.58
|
|
35
|
Haemolysis and sublethal injury of RBCs after routine blood bank manipulations.
|
2011
|
1.57
|
|
36
|
Low-level viraemia of hepatitis B virus in an anti-HBc- and anti-HBs-positive blood donor.
|
2004
|
1.56
|
|
37
|
Hepatitis B virus DNA in blood donors with anti-HBc as a possible indicator of active hepatitis B virus infection in Yucatan, Mexico.
|
2005
|
1.55
|
|
38
|
What population factors influence the decision to donate blood?
|
2004
|
1.54
|
|
39
|
Guideline on the clinical use of apheresis procedures for the treatment of patients and collection of cellular therapy products.
|
2015
|
1.52
|
|
40
|
The administration of blood and blood components and the management of transfused patients. British Committee for Standards in Haematology, Blood Transfusion Task Force. Royal College of Nursing and the Royal College of Surgeons of England.
|
1999
|
1.52
|
|
41
|
Routine antenatal anti-D prophylaxis.
|
2012
|
1.51
|
|
42
|
Prevalence and epidemiological characteristics of hepatitis C in Scottish blood donors.
|
1994
|
1.51
|
|
43
|
Towards better blood transfusion--recruitment and training.
|
2009
|
1.51
|
|
44
|
Red cell freezing and its impact on the supply chain.
|
2004
|
1.50
|
|
45
|
Are quality differences responsible for different adverse reactions reported for SD-plasma from USA and Europe?
|
2006
|
1.49
|
|
46
|
Limited efficacy of universal leucodepletion in reducing the incidence of febrile nonhaemolytic reactions in red cell transfusions.
|
2002
|
1.49
|
|
47
|
Is there a right to donate blood? Patient rights; donor responsibilities.
|
2007
|
1.49
|
|
48
|
Trends in prevalence of hepatitis B virus infection among Iranian blood donors, 1998-2007.
|
2009
|
1.47
|
|
49
|
Transfusion trigger--how precise are we? Intraoperative blood transfusion practices in a tertiary centre in Nigeria.
|
2008
|
1.46
|
|
50
|
Transfusion-transmitted infections among multitransfused patients in Iran: a review.
|
2007
|
1.46
|